Psychedelic Pharmacists Association

What Psychedelic Pharmacists Association does

The Psychedelic Pharmacists Association (PPA) is a U.S.-headquartered nonprofit professional association, founded in 2020 and based in Portland, Oregon, that serves pharmacists, pharmacy students, and pharmacist-allied clinicians interested in the therapeutic use of psychedelic medicines. The organization positions itself as a global community advocating for the role of pharmacists in psychedelic care and offers three annual membership tiers — Pharmacist, Student, and Associate — each granting access to committees, mentorship, teaching opportunities, and regular events connecting members with clinicians and researchers. Its core commercial product is the standalone "Breakthrough Psychedelic Curriculum," a comprehensive educational course sold via one-time payment that is available independently of membership.

The PPA operates entirely on third-party infrastructure: its community platform is built on Mighty Networks, donations are processed through Donorbox, and its newsletter distribution runs on Flodesk. It maintains an organic social presence on LinkedIn, Instagram, X, and YouTube, with the latter featuring an overview video from the Association President. The website serves as the primary top-of-funnel surface for membership enrollment and course purchase, with no mobile app, API, or proprietary technology platform disclosed.

The business model is a hybrid of three revenue streams: recurring membership dues (annual subscriptions across three tiers), one-time course sales for the curriculum, and voluntary donations from members and non-members. No pricing, revenue figures, sponsorship deals, grants, or membership counts are publicly disclosed. The organization has no board, management team, parent company, or funding rounds disclosed in available materials, and employs 8 people globally. The operating premise is contingent on the evolving academic and regulatory landscape for psychedelic therapies, which the PPA explicitly identifies as the catalyst for establishing the pharmacist's role in this emerging field.

Name

Psychedelic Pharmacists Association

Legal name

Psychedelic Pharmacists Association

Website

https://psychedelicpharmacist.mn.co

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

The Psychedelic Pharmacists Association is a nonprofit professional membership association serving pharmacists, pharmacy students, and clinician allies worldwide, offering education, mentorship, and a standalone psychedelic therapy curriculum funded by dues, course sales, and donations.

Ownership category

akta.pro rank

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Membership Fees: Non-profit association funded primarily through membership dues from pharmacist, student, and associate members.
2. Educational Course Sales: The Breakthrough Psychedelic Curriculum is sold as a standalone educational resource through one-time payment, available independent of membership.
3. Donations: The organization accepts donations from both members and non-members to support educational opportunities for pharmacists and healthcare providers.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

The Psychedelic Pharmacists Association (PPA) is a global non-profit professional association that provides pharmacist, student, and associate memberships giving access to committees, mentorship, teaching opportunities, and educational events centered on psychedelic medicine. The PPA also sells a standalone Breakthrough Psychedelic Curriculum course via one-time payment, available to members and non-members alike.

Product overview

The Psychedelic Pharmacists Association offers a membership-based community platform centered around its PPA Breakthrough Psychedelic Curriculum educational course. The core offering includes pharmacist, student, and associate memberships that provide access to committees, mentorship, teaching opportunities, and regular events connecting members with clinicians and researchers. The standalone course can be purchased separately for those seeking psychedelic therapy education without membership.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmacist Membership
• Student Membership
• Associate Membership
• PPA Breakthrough Psychedelic Curriculum

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Emerging players

• Chacruna Institute: Chacruna is a nonprofit promoting the responsible integration of psychedelics through education, conferences, and advocacy. It targets a wider psychedelic-literate professional audience rather than pharmacists specifically, making it a thematic peer in psychedelic continuing education.
• Usona Institute: Usona is a nonprofit psychedelic research organization conducting psilocybin clinical trials and supporting education. It overlaps with PPA on psychedelic-medicine content development and clinician outreach, but as a research sponsor rather than a membership body.
• Psychedelic Science Review (by Psychedelic Science Fund): Psychedelic Science Review produces peer-reviewed-aligned educational content on psychedelic pharmacology and clinical evidence. It competes with PPA's Breakthrough Curriculum for the same clinician/learner audience studying psychedelics.

Broad incumbents

• Multidisciplinary Association for Psychedelic Studies (MAPS): MAPS is the largest nonprofit advocating for psychedelic medicines, funding research, policy reform, and education. It overlaps with PPA on psychedelic medicine advocacy and clinician education but operates at a far larger scale across all clinical disciplines rather than focusing on pharmacists.
• American Pharmacists Association (APhA): APhA is the largest US-based professional association for pharmacists, providing education, advocacy, and practice resources. It is the broad incumbent in the same professional-association space PPA occupies, and could plausibly absorb psychedelic curriculum into its existing CE-accredited catalog.
• American Society of Health-System Pharmacists (ASHP): ASHP is the major professional association for hospital and health-system pharmacists, offering training, advocacy, and credentialing. Like APhA, it serves as a broad incumbent with the infrastructure to add specialty content in psychedelic pharmacy.

Direct peers

• Society of Cannabis Clinicians: Society of Cannabis Clinicians is a membership organization training clinicians on cannabis therapeutics — the closest analog in scope and shape to PPA among currently illegal/controlled-substance clinician associations, sharing similar legal, educational, and professional-identity challenges.
• American Association of Psychiatric Pharmacists (AAPP): AAPP is a specialty pharmacist association focused on psychiatric and neurologic pharmacotherapy, the closest existing specialty-pharmacist organization to PPA. Its membership and education model mirror PPA's, and psychedelic psychiatry is directly within its therapeutic scope.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/psypharmacists
• YouTubeyoutube.com/@psypharmacists
• LinkedInlinkedin.com/company/psychedelic-pharmacists-association
• Instagraminstagram.com/psypharmacists

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Psychedelic Pharmacists Association